Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Segment Information (Tables)

v3.10.0.1
Segment Information (Tables)
12 Months Ended
Dec. 31, 2018
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The following table summarizes segment information for the years ended December 31, 2018, 2017 and 2016 (in thousands).  
  For the Years Ended December 31,
  2018 2017
(as adjusted)
2016
(as adjusted)
Net Revenues:      
Clinical Services $ 241,873  $ 213,097  $ 210,159 
Pharma Services 34,868  27,154  21,649 
Total Revenue $ 276,741  $ 240,251  $ 231,808 
Cost of Revenue:
Clinical Services $ 128,297  $ 121,785  $ 120,437 
Pharma Services 21,179  16,510  13,267 
Total Cost of Revenue $ 149,476  $ 138,295  $ 133,704 
Gross Margin:
Clinical Services $ 113,576  $ 91,313  $ 89,722 
Pharma Services 13,689  10,643  8,382 
Total Gross Margin $ 127,265  $ 101,956  $ 98,104